Skip to main content
MedPathMedPath Home
Clinical Trials/NCT02497092
NCT02497092
Unknown
Not Applicable

Effect of Different Injection Techniques on Pain Level in Intravitreal Injections

Rabin Medical Center1 site in 1 country300 target enrollmentAugust 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsInjection Site Discomfort

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Injection Site Discomfort
Sponsor
Rabin Medical Center
Enrollment
300
Locations
1
Primary Endpoint
Pain during the injection as measured by the "Pain numeric rating scale"
Last Updated
10 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The purpose of this study is to determine whether certain intravitreal injection techniques cause less pain than others and would therefore be beneficial for the patient's well being.

Registry
clinicaltrials.gov
Start Date
August 2015
End Date
August 2016
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Amir Sternfeld

MD

Rabin Medical Center

Eligibility Criteria

Inclusion Criteria

  • •Patients receiving intravitreal anti vascular endothelial growth factor (VEGF) injections
  • •Informed consent

Exclusion Criteria

  • •Dementia or any other reason for cognitive deterioration
  • •Technical limitations not allowing injecting by the protocol

Outcomes

Primary Outcomes

Pain during the injection as measured by the "Pain numeric rating scale"

Time Frame: Up to 2 minutes after the injection

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 2
Evaluation of Inflammation and Pain Post Injection of Ranibizumab vs Aflibercept in Patients With DMEDiabetic Macular Edema
NCT02363621Arshad Khanani101
Recruiting
Phase 1
Comparison of the effect of intravitreal injection of bevacizumab (Stevenet) alone with intravitreal injection of bevacizumab and triamcinolone in the treatment of diabetic macular edema with a thickness greater than 500 microns in patients
IRCT20211130053229N1Kerman University of Medical Sciences70
Completed
Phase 4
The effect of two local anaesthetic techniques on pain scores during and after intravitreal injectionRetinal diseaseIntravitreal injectionPeri procedural pain
ACTRN12617000182392Flinders University120
Completed
Phase 1
Evaluation of Pain and Inflammation After Injection of Lucentis vs Eylea for Treatment of Wet Macular DegenerationNeovascular Age-Related Macular Degeneration
NCT01926977Arshad Khanani100
Completed
Phase 3
The study for the effect of intravitreous injection of ranibizumab (product name: Lucentis) and subthreshold laser photocoagulation on diabetic macular edemadiabetic macular edema
JPRN-UMIN000017037Jichi Medica University, Saitama Medical Center100